nodes	percent_of_prediction	percent_of_DWPC	metapath
Methacholine—CHRM3—Amine ligand-binding receptors—HRH3—narcolepsy	0.0327	0.0327	CbGpPWpGaD
Methacholine—CHRM2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0323	0.0323	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Other—P2RY11—narcolepsy	0.0305	0.0305	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Other—P2RY11—narcolepsy	0.0303	0.0303	CbGpPWpGaD
Methacholine—CHRM3—Monoamine GPCRs—HTR2A—narcolepsy	0.0194	0.0194	CbGpPWpGaD
Methacholine—CHRM2—Monoamine GPCRs—HTR2A—narcolepsy	0.0192	0.0192	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0178	0.0178	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0178	0.0178	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—P2RY11—narcolepsy	0.0172	0.0172	CbGpPWpGaD
Methacholine—CHRM3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0163	0.0163	CbGpPWpGaD
Methacholine—CHRM2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0161	0.0161	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0159	0.0159	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0159	0.0159	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0154	0.0154	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—HCRT—narcolepsy	0.0146	0.0146	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0136	0.0136	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0136	0.0136	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0133	0.0133	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0131	0.0131	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0131	0.0131	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0117	0.0117	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0117	0.0117	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0114	0.0114	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—TRH—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Methacholine—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0099	0.0099	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00967	0.00967	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00957	0.00957	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.0092	0.0092	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.00897	0.00897	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.00897	0.00897	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00888	0.00888	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00888	0.00888	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00866	0.00866	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00862	0.00862	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.0086	0.0086	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00857	0.00857	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00853	0.00853	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00852	0.00852	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00804	0.00804	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00804	0.00804	CbGpPWpGaD
Methacholine—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.008	0.008	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0075	0.0075	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00743	0.00743	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00736	0.00736	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00733	0.00733	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00729	0.00729	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00726	0.00726	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00719	0.00719	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00719	0.00719	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00656	0.00656	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.0065	0.0065	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00643	0.00643	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00636	0.00636	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00558	0.00558	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00554	0.00554	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00553	0.00553	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00532	0.00532	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00532	0.00532	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00527	0.00527	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00527	0.00527	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00507	0.00507	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00507	0.00507	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00502	0.00502	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00502	0.00502	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00489	0.00489	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00489	0.00489	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00485	0.00485	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00485	0.00485	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00484	0.00484	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.0046	0.0046	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.0046	0.0046	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00456	0.00456	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00456	0.00456	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00444	0.00444	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.0044	0.0044	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00433	0.00433	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00416	0.00416	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00412	0.00412	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00401	0.00401	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00401	0.00401	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00378	0.00378	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00374	0.00374	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00374	0.00374	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00371	0.00371	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0037	0.0037	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CHKB—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00367	0.00367	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00337	0.00337	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00333	0.00333	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0032	0.0032	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00317	0.00317	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00315	0.00315	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00312	0.00312	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.00286	0.00286	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.00276	0.00276	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.00269	0.00269	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.00269	0.00269	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CPT1B—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.00242	0.00242	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.00221	0.00221	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PENK—narcolepsy	0.00199	0.00199	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PENK—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TRH—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TRH—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NPS—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NPS—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000739	0.000739	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000732	0.000732	CbGpPWpGaD
